Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries

Elena Dudukina,Szimonetta Komjáthiné Szépligeti,Pär Karlsson,Kofi Asomaning,Anne Kjersti Daltveit,Katja Hakkarainen,Fabian Hoti,Helle Kieler,Astrid Lunde,Ingvild Odsbu,Matti Rantanen,Johan Reutfors,Laura Saarelainen,Vera Ehrenstein,Gunnar Toft
DOI: https://doi.org/10.1007/s40264-023-01307-2
2023-04-27
Drug Safety
Abstract:Pregabalin is an antiepileptic drug frequently prescribed to pregnant women. Risks of adverse birth and postnatal neurodevelopmental outcomes following prenatal exposure to pregabalin are uncertain.
pharmacology & pharmacy,public, environmental & occupational health,toxicology
What problem does this paper attempt to address?